PMS49 Fatigue is an Independent Variable Predicting Physical Function and Das-28 Remission for Patients with Rheumatoid Arthritis Treated with Intravenously Administered Golimumab- Results from a Phase 3, Placebo Controlled Clinical Trial
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.238
https://www.valueinhealthjournal.com/article/S1098-3015(12)00303-8/fulltext
Title :
PMS49 Fatigue is an Independent Variable Predicting Physical Function and Das-28 Remission for Patients with Rheumatoid Arthritis Treated with Intravenously Administered Golimumab- Results from a Phase 3, Placebo Controlled Clinical Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00303-8&doi=10.1016/j.jval.2012.03.238
First page :
A42
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
1014